Health and Human Services Department, Food and Drug Administration
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2011-N-0002] AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Cardiovascular and Renal Drugs Advisory Committee. General Function of the Committee: To provide advice and recommendations to the Agency on FDA's regulatory issues. Date and Time: The meeting will be held on February 23, 2012, from 8 a.m. to 5 p.m. Location: Hilton Washington DC/Silver Spring, The Ballrooms, 8727 Colesville Rd., Silver Spring, MD 20910. The hotel's telephone number is (301) 589-5200. Contact Person: Kristina Toliver, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, rm. 2417, Silver Spring, MD 20993-0002, (301) 796-9001, Fax: (301) 847-8533, email: CRDAC@fda.hhs.gov , or FDA Advisory Committee Information Line, 1 (800) 741-8138 ((301) 443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency's Web site and call the approp…
Other Federal Register documents from the same docket.
Ethical and Regulatory Challenges in the Development of Pediatric Medical Countermeasures; Public Workshop
Oncologic Drugs Advisory Committee; Notice of Meeting
Oncologic Drugs Advisory Committee; Notice of Meeting
Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting
Request for Nominations for Voting Members on a Public Advisory Committee; Food Advisory Committee
Citation: 76 FR 82310
